EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cover Picture

Animal Models and Experimental Medicine · 2026-07 · 9 (7)

DOI: 10.1002/ame2.70279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 30.07.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

This cover image is based on the article “Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection“ (https://doi.org/10.1002/ame2.70211) reported by Zifan Li1, Yu Kang, Yuyu Niu. This review highlights recent progress in pluripotent stem cell-derived β-cell therapy for type 1 diabetes, spanning differentiation, preclinical validation, and early clinical translation. Refined induction protocols now produce enriched insulin-secreting islet-like cells capable of reversing hyperglycemia in diabetic rodents and nonhuman primates, with early clinical studies showing insulin independence in selected patients. Despite this promise, immune rejection remains the key challenge. Biomaterial encapsulation and CRISPR-mediated hypoimmunogenic cell engineering are emerging as promising strategies to overcome this barrier, while incomplete maturation and batch-to-batch heterogeneity continue to hinder clinical translation. Looking ahead, the development of scalable, durable, and immunosuppression-free cell-based therapies for diabetes will remain a major focus of future research.

Zitieren

APA

(2026). Cover Picture. Animal Models and Experimental Medicine, 9(7). https://doi.org/10.1002/ame2.70279

Vancouver

Cover Picture. Animal Models and Experimental Medicine. 2026;9(7). doi:10.1002/ame2.70279

BibTeX
@article{euvimed2026,
  title = {Cover Picture},
  journal = {Animal Models and Experimental Medicine},
  year = {2026},
  volume = {9},
  number = {7},
  doi = {10.1002/ame2.70279}
}
Kostenlos starten →